Your browser doesn't support javascript.
loading
WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma.
Mitchell, Kelly; Sprowls, Samuel A; Arora, Sonali; Shakya, Sajina; Silver, Daniel J; Goins, Christopher M; Wallace, Lisa; Roversi, Gustavo; Schafer, Rachel E; Kay, Kristen; Miller, Tyler E; Lauko, Adam; Bassett, John; Kashyap, Anjali; D'Amato Kass, Jonathan; Mulkearns-Hubert, Erin E; Johnson, Sadie; Alvarado, Joseph; Rich, Jeremy N; Holland, Eric C; Paddison, Patrick J; Patel, Anoop P; Stauffer, Shaun R; Hubert, Christopher G; Lathia, Justin D.
Afiliación
  • Mitchell K; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44106, USA.
  • Sprowls SA; Case Comprehensive Cancer Center, Cleveland, Ohio 44106, USA.
  • Arora S; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44106, USA.
  • Shakya S; Case Comprehensive Cancer Center, Cleveland, Ohio 44106, USA.
  • Silver DJ; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington 98109, USA.
  • Goins CM; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44106, USA.
  • Wallace L; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44106, USA.
  • Roversi G; Case Comprehensive Cancer Center, Cleveland, Ohio 44106, USA.
  • Schafer RE; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44106, USA.
  • Kay K; Center for Therapeutics Discovery, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44106, USA; lathiaj@ccf.org christopher.hubert@case.edu.
  • Miller TE; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44106, USA.
  • Lauko A; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44106, USA.
  • Bassett J; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44106, USA.
  • Kashyap A; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44106, USA.
  • D'Amato Kass J; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44106, USA.
  • Mulkearns-Hubert EE; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44106, USA.
  • Johnson S; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
  • Alvarado J; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA.
  • Rich JN; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44106, USA.
  • Holland EC; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44106, USA.
  • Paddison PJ; Department of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
  • Patel AP; Medical Scientist Training Program, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA.
  • Stauffer SR; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington 98109, USA.
  • Hubert CG; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44106, USA.
  • Lathia JD; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44106, USA.
Genes Dev ; 37(3-4): 86-102, 2023 02 01.
Article en En | MEDLINE | ID: mdl-36732025

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Glioblastoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Genes Dev Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Glioblastoma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Genes Dev Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos